Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 2,432 | 3,022 | 7,050 | 5,998 | 4,406 |
| Operating Income | -2,432 | -3,022 | -7,050 | -5,998 | -4,406 |
| Interest Expense | 0 | 0 | 0 | 230 | 80 |
| Other Income | -6,646 | 1,399 | -847 | -300 | 154 |
| Pre-tax Income | -9,078 | -1,623 | -7,897 | -6,528 | -4,332 |
| Net Income Continuous | -9,078 | -1,623 | -7,897 | -6,528 | -4,332 |
| Net Income | $-9,078 | $-1,623 | $-7,897 | $-6,528 | $-4,332 |
| EPS Basic Total Ops | -0.72 | -0.15 | -0.75 | -0.74 | -0.37 |
| EPS Basic Continuous Ops | -0.72 | -0.15 | -0.75 | -0.74 | -0.39 |
| EPS Diluted Total Ops | -0.72 | -0.15 | -0.75 | -0.74 | -0.37 |
| EPS Diluted Continuous Ops | -0.72 | -0.15 | -0.75 | -0.74 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.15 | -0.75 | N/A | N/A |
| EBITDA(a) | $-2,431 | $-3,020 | $-7,049 | $-5,997 | $-4,405 |